Feelemyer-276x303 photo
Jonathan Feelemyer, PhD, MS, MPhil
NYU School of Global Public Health - Project Director
PhD, Epidemiology, NYU Grossman School of Medicine
MPhil, Epidemiology, NYU Grossman School of Medicine
MS, Epidemiology, University at Albany School of Public Health
BA, Health and Society, University of Rochester
Research Interests
Injecting drug use, epidemiology, HIV, HCV, sexually transmitted diseases, harm reduction, research synthesis
Jonathan Feelemyer is a project director at the NYU School of Global Public Health.  His research interests include HIV, hepatitis C, sexually transmitted diseases, injection drug use, and harm reduction for at risk populations. His research is focused on international settings specifically in Southeast Asia and Eastern Europe. He has published numerous publications in academic journals and has presented his work at national and international conferences.  He has collaborated with researchers from New York University, Columbia University, the Centers for Disease Control and Prevention, and researchers in Estonia, Vietnam, Russia, France, and other countries.  He has worked collaboratively on numerous meta-analysis and systematic review studies, synthesizing research from multiple countries and time periods examining different research topics related to HIV and HCV.  He currently works with Dr. Don Des Jarlais on research projects addressing harm reduction, combined prevention, and reductions in HIV and HCV among different at risk populations, with special focus on high prevalence settings worldwide.
Principal Investigator, Comparison of Stigmatization of Monkeypox, Injecting Drug Use, HIV/AIDS, and COVID-19. Completed


Feelemyer J, Braithwaite RS, Zhou Q, Cleland CM, Manandhar-Sasaki P, Wilton L, Ritchie A, Collins LM, Gwadz MV (2024).
Empirical development of a behavioral intervention for African American/Black and Latino persons with unsuppressed HIV viral load levels: An application of the Multiphase Optimization Strategy (MOST) using cost-effectiveness as an optimization objective
AIDS and Behavior [Epub 2024 Apr 25]. doi: 10.1007/s10461-024-04335-w.

Feelemyer J, Duncan DT, Akhidenor N, Mazumdar M, Irvine NM, Scheidell JD, Brewer RA, Turpin RE, Hucks-Ortiz C, Dyer TV, Cleland CM, Mayer KH, Khan MR (2024).
Police harassment and psychiatric, sexual, and substance use risk among Black sexual minority men and Black transgender women in the HIV Prevention Trials 061 cohort
Journal of Racial and Ethnic Health Disparities [Epub 2024 Apr 12]. doi: 10.1007/s40615-024-01909-1.

Feelemyer J, Des Jarlais DC, Nagot N, Huong DT, Oanh KTH, Khue PM, Giang HT, Thanh NTT, Cleland CM, Arasteh K, Caniglia E, Chen Y, Bart G, Moles JP, Vinh VH, Vallo R, Quillet C, Rapoud D, Le SM, Michel L, Laureillard D, Khan MR (2024).
Utility of self-report antiretroviral adherence for predicting HIV viral load among persons who inject drugs in Hai Phong Vietnam: Assessing differences by methamphetamine use
AIDS Care, 36 (4), 553-560. doi: 10.1080/09540121.2023.2275041. PMCID: PMC10932855.

Feelemyer J, Bershteyn A, Scheidell JD, Brewer R, Dyer TV, Cleland CM, Hucks-Ortiz C, Justice A, Mayer K, Grawert A, Kaufman JS, Braithwaite S, Khan MR (2024).
Impact of decarceration plus alcohol, substance use, and mental health screening on life expectancies of Black sexual minority men and Black transgender women (BSMM/BTW) living with HIV in the United States: A simulation study based on HPTN 061
Journal of Acquired Immune Deficiency Syndromes, 95 (1), 283-290. doi: 10.1097/QAI.0000000000003354. PMCID: PMC10922416.

Engelberg R, Hood Q, Shah K, Parent B, Martin J, Turpin R, Feelemyer J, Khan M, Vieira D (2023).
Challenges unique to transgender persons in US correctional settings: A scoping review
Journal of Urban Health, 100 (6), 1170-1189. doi: 10.1007/s11524-023-00794-z. PMCID: PMC10728397.


Feelemyer J, Des Jarlais D, Arasteh K, Abdul-Quader AS, Hagan H (2014).
Retention of participants in medication-assisted programs in low- and middle-income countries: An international systematic review
Addiction, 109 (1), 20-32. doi: 10.1111/add.12303. PMCID: PMC5312702.

Feelemyer J, Des Jarlais DC, Arasteh K, Phillips BW, Hagan H (2014).
Changes in quality of life (WHOQOL-BREF) and addiction severity index (ASI) among participants in opioid substitution treatment (OST) in low and middle income countries: An international systematic review
Drug and Alcohol Dependence, 134, 251-258. doi: 10.1016/j.drugalcdep.2013.10.011. PMCID: PMC3880839.

Feelemyer J, Des Jarlais D, Arasteh K, Uuskula A (2015).
Adherence to antiretroviral medications among persons who inject drugs in transitional, low and middle income countries: An international systematic review
AIDS and Behavior, 19 (4), 575-583. doi: 10.1007/s10461-014-0928-3. PMCID: PMC4393761.

Jonathan Feelemyer's ResearchGate Profile